|Day Low/High||0.32 / 0.39|
|52 Wk Low/High||0.31 / 3.84|
Presentation will highlight additional analyses of the CHABLIS-SC1, Phase 3 clinical study of blisibimod
Presentation to highlight data from the CHABLIS-SC1, Phase 3 clinical study of blisibimod
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.